BioBotanic
Corporation
BioBotanic Corp is a research company engaged in herbal medicine mechanism elucidations and clinical trials. Company owns multiple international intellectual properties in wound healing, antibiotics, and restorative injury repair.
Company currently has two major product lines:
Lyzenic tm A cocktail formulation drug for skin wound healing with multiple indications. $500 million - $1 billion market size.
Zalthanol tm A scar removal drug with potential market size of $300 million per year.
Our current research interests cover the following areas:
Enzymatic debridement agents
Local and systemic antibiotics
Human tissue growth factor stimulation and secretion.
Scar tissue formation and metabolism.
Our core competency is the knowledge and experience of formulating full range wound healing treatment agents using botanical materials, -- more natural ways of healing. These treatments are being used clinically in treating acute deep burns, chronic unhealed burns and other chronic wounds. (For example, by Dr. Zhao.) Our objective is to make the herbal medicines safer, more effective and easier to use.
